Characterization of the glucagon response to hypoglycemia in man

J. E. Gerich, V. Schneider, S. E. Dippe, M. Langlois, C. Noacco, J. H. Karam, P. H. Forsham

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The present investigation was undertaken to characterize glucagon responses to hypoglycemia in man. Using a highly specific antiserum, plasma immunoreactive glucagon levels were determined during episodes of insulin induced hypoglycemia in 15 normal subjects and during oral glucose tolerance tests in 4 subjects with reactive hypoglycemia. During insulin induced hypoglycemia, plasma glucagon rose from a mean (± SEM) basal level of 143 ± 6.5 pg/ml to a maximum of 471 ± 15 pg/ml at 45 min, p<.001. Initial glucagon responses were evident 15 min after insulin administration and preceded those of cortisol and growth hormone. Total glucagon responses (area under curve) correlated positively with the total decrease in plasma glucose (area below basal), r = 0.852, p<0.0005, rather than the nadir or absolute level of hypoglycemia achieved. Hyperglycemia induced by 60 min glucose infusions, which suppressed basal glucagon secretion, did not prevent glucagon responses to subsequent insulin induced hypoglycemia. Moreover the fall in plasma glucose from a mean of 187 mg/100 ml to 112 mg/100 ml was sufficient to stimulate glucagon secretion. In all subjects with reactive hypoglycemia plasms glucagon rose at least 2 times basal. Thus, in man, hypoglycemia is a potent stimulus for glucagon secretion. The rate of fall of plasma glucose as well as the degree and duration of hypoglycemia are important determinants of the glucagon response. These findings suggest that pancreatic glucagon may function physiologically as a hypoglycemic counter regulatory hormone, and that glucagon responses to hypoglycemia may provide an additional parameter with which to assess pancreatic alpha cell function in man.

Original languageEnglish (US)
Pages (from-to)77-82
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume38
Issue number1
StatePublished - 1974
Externally publishedYes

Fingerprint

Glucagon
Hypoglycemia
Plasmas
Glucose
Insulin
Glucagon-Secreting Cells
Glucose Tolerance Test
Hypoglycemic Agents
Hyperglycemia
Growth Hormone
Area Under Curve
Hydrocortisone
Immune Sera
Hormones

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Gerich, J. E., Schneider, V., Dippe, S. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1974). Characterization of the glucagon response to hypoglycemia in man. Journal of Clinical Endocrinology and Metabolism, 38(1), 77-82.

Characterization of the glucagon response to hypoglycemia in man. / Gerich, J. E.; Schneider, V.; Dippe, S. E.; Langlois, M.; Noacco, C.; Karam, J. H.; Forsham, P. H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 38, No. 1, 1974, p. 77-82.

Research output: Contribution to journalArticle

Gerich, JE, Schneider, V, Dippe, SE, Langlois, M, Noacco, C, Karam, JH & Forsham, PH 1974, 'Characterization of the glucagon response to hypoglycemia in man', Journal of Clinical Endocrinology and Metabolism, vol. 38, no. 1, pp. 77-82.
Gerich JE, Schneider V, Dippe SE, Langlois M, Noacco C, Karam JH et al. Characterization of the glucagon response to hypoglycemia in man. Journal of Clinical Endocrinology and Metabolism. 1974;38(1):77-82.
Gerich, J. E. ; Schneider, V. ; Dippe, S. E. ; Langlois, M. ; Noacco, C. ; Karam, J. H. ; Forsham, P. H. / Characterization of the glucagon response to hypoglycemia in man. In: Journal of Clinical Endocrinology and Metabolism. 1974 ; Vol. 38, No. 1. pp. 77-82.
@article{941965cfb8f74f0c9aba1467248d89ae,
title = "Characterization of the glucagon response to hypoglycemia in man",
abstract = "The present investigation was undertaken to characterize glucagon responses to hypoglycemia in man. Using a highly specific antiserum, plasma immunoreactive glucagon levels were determined during episodes of insulin induced hypoglycemia in 15 normal subjects and during oral glucose tolerance tests in 4 subjects with reactive hypoglycemia. During insulin induced hypoglycemia, plasma glucagon rose from a mean (± SEM) basal level of 143 ± 6.5 pg/ml to a maximum of 471 ± 15 pg/ml at 45 min, p<.001. Initial glucagon responses were evident 15 min after insulin administration and preceded those of cortisol and growth hormone. Total glucagon responses (area under curve) correlated positively with the total decrease in plasma glucose (area below basal), r = 0.852, p<0.0005, rather than the nadir or absolute level of hypoglycemia achieved. Hyperglycemia induced by 60 min glucose infusions, which suppressed basal glucagon secretion, did not prevent glucagon responses to subsequent insulin induced hypoglycemia. Moreover the fall in plasma glucose from a mean of 187 mg/100 ml to 112 mg/100 ml was sufficient to stimulate glucagon secretion. In all subjects with reactive hypoglycemia plasms glucagon rose at least 2 times basal. Thus, in man, hypoglycemia is a potent stimulus for glucagon secretion. The rate of fall of plasma glucose as well as the degree and duration of hypoglycemia are important determinants of the glucagon response. These findings suggest that pancreatic glucagon may function physiologically as a hypoglycemic counter regulatory hormone, and that glucagon responses to hypoglycemia may provide an additional parameter with which to assess pancreatic alpha cell function in man.",
author = "Gerich, {J. E.} and V. Schneider and Dippe, {S. E.} and M. Langlois and C. Noacco and Karam, {J. H.} and Forsham, {P. H.}",
year = "1974",
language = "English (US)",
volume = "38",
pages = "77--82",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Characterization of the glucagon response to hypoglycemia in man

AU - Gerich, J. E.

AU - Schneider, V.

AU - Dippe, S. E.

AU - Langlois, M.

AU - Noacco, C.

AU - Karam, J. H.

AU - Forsham, P. H.

PY - 1974

Y1 - 1974

N2 - The present investigation was undertaken to characterize glucagon responses to hypoglycemia in man. Using a highly specific antiserum, plasma immunoreactive glucagon levels were determined during episodes of insulin induced hypoglycemia in 15 normal subjects and during oral glucose tolerance tests in 4 subjects with reactive hypoglycemia. During insulin induced hypoglycemia, plasma glucagon rose from a mean (± SEM) basal level of 143 ± 6.5 pg/ml to a maximum of 471 ± 15 pg/ml at 45 min, p<.001. Initial glucagon responses were evident 15 min after insulin administration and preceded those of cortisol and growth hormone. Total glucagon responses (area under curve) correlated positively with the total decrease in plasma glucose (area below basal), r = 0.852, p<0.0005, rather than the nadir or absolute level of hypoglycemia achieved. Hyperglycemia induced by 60 min glucose infusions, which suppressed basal glucagon secretion, did not prevent glucagon responses to subsequent insulin induced hypoglycemia. Moreover the fall in plasma glucose from a mean of 187 mg/100 ml to 112 mg/100 ml was sufficient to stimulate glucagon secretion. In all subjects with reactive hypoglycemia plasms glucagon rose at least 2 times basal. Thus, in man, hypoglycemia is a potent stimulus for glucagon secretion. The rate of fall of plasma glucose as well as the degree and duration of hypoglycemia are important determinants of the glucagon response. These findings suggest that pancreatic glucagon may function physiologically as a hypoglycemic counter regulatory hormone, and that glucagon responses to hypoglycemia may provide an additional parameter with which to assess pancreatic alpha cell function in man.

AB - The present investigation was undertaken to characterize glucagon responses to hypoglycemia in man. Using a highly specific antiserum, plasma immunoreactive glucagon levels were determined during episodes of insulin induced hypoglycemia in 15 normal subjects and during oral glucose tolerance tests in 4 subjects with reactive hypoglycemia. During insulin induced hypoglycemia, plasma glucagon rose from a mean (± SEM) basal level of 143 ± 6.5 pg/ml to a maximum of 471 ± 15 pg/ml at 45 min, p<.001. Initial glucagon responses were evident 15 min after insulin administration and preceded those of cortisol and growth hormone. Total glucagon responses (area under curve) correlated positively with the total decrease in plasma glucose (area below basal), r = 0.852, p<0.0005, rather than the nadir or absolute level of hypoglycemia achieved. Hyperglycemia induced by 60 min glucose infusions, which suppressed basal glucagon secretion, did not prevent glucagon responses to subsequent insulin induced hypoglycemia. Moreover the fall in plasma glucose from a mean of 187 mg/100 ml to 112 mg/100 ml was sufficient to stimulate glucagon secretion. In all subjects with reactive hypoglycemia plasms glucagon rose at least 2 times basal. Thus, in man, hypoglycemia is a potent stimulus for glucagon secretion. The rate of fall of plasma glucose as well as the degree and duration of hypoglycemia are important determinants of the glucagon response. These findings suggest that pancreatic glucagon may function physiologically as a hypoglycemic counter regulatory hormone, and that glucagon responses to hypoglycemia may provide an additional parameter with which to assess pancreatic alpha cell function in man.

UR - http://www.scopus.com/inward/record.url?scp=0015988740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015988740&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 77

EP - 82

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -